Die adjuvante Nachbestrahlung reduziert die Lokalrezidivrate auch beim prognostisch günstigen DCIS der Brust signifikant

Pahl, René; Dunst, Jürgen

doi:10.1007/s00066-015-0906-3

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2017

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…42% of local failures in the observation arm were invasive recurrences. The rate of contralateral invasive breast cancer (4% at 7 years) was considerably lower than the rate of ipsilateral local failure after radiotherapy, suggesting that radiotherapy could prevent secondary tumors [45]. Toxicity associated with radiotherapy was generally low.…”

Section: Introductionmentioning

confidence: 99%

Current controversies in radiotherapy for breast cancer

et al. 2017

Self Cite

View full text Add to dashboard Cite

Multimodal treatment approaches have substantially improved the outcome of breast cancer patients in the last decades. Radiotherapy is an integral component of multimodal treatment concepts used in curative and palliative intention in numerous clinical situations from precursor lesions such as ductal carcinoma in situ (DCIS) to advanced breast cancer. This review addresses current controversial topics in radiotherapy with special consideration of DCIS, accelerated partial breast irradiation (APBI) and regional nodal irradiation (RNI) and provides an update on the clinical practice guidelines of the Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).

show abstract

Section: Introductionmentioning

confidence: 99%